Concepts (128)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electroencephalography | 7 | 2024 | 897 | 1.780 |
Why?
|
| Thrombolytic Therapy | 2 | 2019 | 214 | 1.010 |
Why?
|
| Phosphopyruvate Hydratase | 2 | 2018 | 31 | 0.990 |
Why?
|
| Stroke | 3 | 2019 | 1079 | 0.920 |
Why?
|
| Hypothermia, Induced | 2 | 2018 | 170 | 0.890 |
Why?
|
| Brain Injuries | 2 | 2025 | 717 | 0.750 |
Why?
|
| Heart Arrest | 2 | 2018 | 375 | 0.720 |
Why?
|
| Critical Care | 3 | 2025 | 693 | 0.700 |
Why?
|
| Pyramidal Tracts | 1 | 2020 | 37 | 0.650 |
Why?
|
| Cordotomy | 1 | 2020 | 14 | 0.650 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2021 | 97 | 0.640 |
Why?
|
| Cerebral Angiography | 2 | 2016 | 106 | 0.640 |
Why?
|
| Cerebrovascular Circulation | 2 | 2025 | 474 | 0.600 |
Why?
|
| Neurologic Examination | 1 | 2018 | 204 | 0.540 |
Why?
|
| Hypovolemia | 1 | 2016 | 12 | 0.530 |
Why?
|
| Neurosurgical Procedures | 1 | 2020 | 316 | 0.530 |
Why?
|
| Hypoglossal Nerve Diseases | 1 | 2016 | 3 | 0.520 |
Why?
|
| Medulla Oblongata | 1 | 2016 | 23 | 0.510 |
Why?
|
| Meningomyelocele | 1 | 2020 | 255 | 0.510 |
Why?
|
| Coma | 1 | 2015 | 57 | 0.480 |
Why?
|
| Cerebral Hemorrhage | 1 | 2016 | 156 | 0.480 |
Why?
|
| Brain Injuries, Traumatic | 3 | 2025 | 301 | 0.460 |
Why?
|
| Giant Cell Arteritis | 1 | 2015 | 59 | 0.430 |
Why?
|
| Intracranial Embolism | 1 | 2013 | 31 | 0.410 |
Why?
|
| Embolism, Air | 1 | 2013 | 25 | 0.400 |
Why?
|
| Status Epilepticus | 1 | 2015 | 154 | 0.400 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 3 | 2025 | 119 | 0.400 |
Why?
|
| Body Weight | 1 | 2016 | 1041 | 0.390 |
Why?
|
| Iatrogenic Disease | 1 | 2013 | 133 | 0.380 |
Why?
|
| Pain | 1 | 2015 | 476 | 0.380 |
Why?
|
| Nervous System Diseases | 1 | 2015 | 411 | 0.340 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2016 | 2203 | 0.290 |
Why?
|
| Intracranial Pressure | 2 | 2025 | 212 | 0.250 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2016 | 169 | 0.240 |
Why?
|
| Aged | 9 | 2023 | 21789 | 0.240 |
Why?
|
| Prognosis | 4 | 2018 | 5084 | 0.230 |
Why?
|
| Monitoring, Physiologic | 2 | 2025 | 386 | 0.230 |
Why?
|
| Humans | 22 | 2025 | 134143 | 0.230 |
Why?
|
| Switzerland | 2 | 2015 | 15 | 0.220 |
Why?
|
| Neurophysiological Monitoring | 1 | 2024 | 37 | 0.210 |
Why?
|
| Terminology as Topic | 1 | 2025 | 235 | 0.210 |
Why?
|
| Intensive Care Units | 2 | 2024 | 538 | 0.200 |
Why?
|
| Middle Aged | 8 | 2020 | 29395 | 0.200 |
Why?
|
| Catheter-Related Infections | 1 | 2023 | 139 | 0.180 |
Why?
|
| Male | 12 | 2020 | 66171 | 0.180 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2022 | 71 | 0.180 |
Why?
|
| Child Abuse, Sexual | 2 | 2012 | 34 | 0.180 |
Why?
|
| Lactates | 1 | 2021 | 102 | 0.180 |
Why?
|
| Homeostasis | 1 | 2025 | 751 | 0.170 |
Why?
|
| Cross Infection | 1 | 2023 | 344 | 0.160 |
Why?
|
| Spinal Nerve Roots | 1 | 2020 | 20 | 0.160 |
Why?
|
| Evoked Potentials, Motor | 1 | 2020 | 34 | 0.160 |
Why?
|
| Brain Concussion | 1 | 2022 | 238 | 0.160 |
Why?
|
| Monitoring, Intraoperative | 1 | 2020 | 134 | 0.150 |
Why?
|
| Eligibility Determination | 1 | 2019 | 38 | 0.150 |
Why?
|
| Urinary Tract Infections | 1 | 2023 | 313 | 0.150 |
Why?
|
| Brain Ischemia | 1 | 2022 | 278 | 0.150 |
Why?
|
| Female | 11 | 2020 | 72002 | 0.150 |
Why?
|
| Survivors | 1 | 2021 | 358 | 0.150 |
Why?
|
| Administration, Intravenous | 1 | 2019 | 162 | 0.150 |
Why?
|
| Registries | 2 | 2016 | 1586 | 0.140 |
Why?
|
| Iohexol | 1 | 2016 | 21 | 0.130 |
Why?
|
| Critical Illness | 2 | 2025 | 629 | 0.130 |
Why?
|
| Anticonvulsants | 2 | 2022 | 396 | 0.130 |
Why?
|
| Surveys and Questionnaires | 2 | 2024 | 4006 | 0.130 |
Why?
|
| Adult | 7 | 2018 | 31943 | 0.130 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 5465 | 0.130 |
Why?
|
| Prospective Studies | 3 | 2022 | 6610 | 0.130 |
Why?
|
| Periodicity | 1 | 2016 | 52 | 0.120 |
Why?
|
| Risk Factors | 3 | 2016 | 11184 | 0.120 |
Why?
|
| Physical Stimulation | 1 | 2015 | 39 | 0.120 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2016 | 154 | 0.120 |
Why?
|
| Cross-Sectional Studies | 1 | 2024 | 3758 | 0.120 |
Why?
|
| Observation | 1 | 2015 | 45 | 0.110 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2017 | 192 | 0.110 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 7232 | 0.110 |
Why?
|
| Hospitals, University | 1 | 2015 | 105 | 0.110 |
Why?
|
| Syndrome | 1 | 2016 | 1176 | 0.100 |
Why?
|
| Neuroimaging | 1 | 2016 | 376 | 0.100 |
Why?
|
| Contrast Media | 1 | 2016 | 517 | 0.100 |
Why?
|
| Criminals | 1 | 2012 | 20 | 0.090 |
Why?
|
| Crime Victims | 1 | 2012 | 70 | 0.090 |
Why?
|
| Pilot Projects | 1 | 2015 | 1493 | 0.090 |
Why?
|
| Recurrence | 1 | 2015 | 1470 | 0.090 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 1486 | 0.090 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 1982 | 0.090 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 2315 | 0.080 |
Why?
|
| Cohort Studies | 2 | 2017 | 5219 | 0.080 |
Why?
|
| Epilepsy | 1 | 2016 | 898 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 1344 | 0.070 |
Why?
|
| Algorithms | 1 | 2015 | 1738 | 0.070 |
Why?
|
| Seizures | 2 | 2022 | 892 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 3508 | 0.060 |
Why?
|
| National Institute of Neurological Disorders and Stroke (U.S.) | 1 | 2025 | 12 | 0.060 |
Why?
|
| Incidence | 1 | 2013 | 3421 | 0.060 |
Why?
|
| Glasgow Coma Scale | 1 | 2025 | 200 | 0.060 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2025 | 152 | 0.060 |
Why?
|
| New York | 1 | 2022 | 73 | 0.050 |
Why?
|
| Time Factors | 1 | 2013 | 6592 | 0.050 |
Why?
|
| Cerebral Infarction | 1 | 2022 | 46 | 0.050 |
Why?
|
| Scalp | 1 | 2022 | 58 | 0.040 |
Why?
|
| Hospitals | 1 | 2023 | 437 | 0.040 |
Why?
|
| Medicare | 1 | 2023 | 466 | 0.040 |
Why?
|
| United States | 2 | 2025 | 11777 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2016 | 17565 | 0.040 |
Why?
|
| Sex Factors | 2 | 2012 | 1387 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2013 | 13098 | 0.030 |
Why?
|
| Ataxin-2 | 1 | 2017 | 10 | 0.030 |
Why?
|
| C9orf72 Protein | 1 | 2017 | 51 | 0.030 |
Why?
|
| DNA Repeat Expansion | 1 | 2017 | 79 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2017 | 160 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2017 | 780 | 0.030 |
Why?
|
| International Cooperation | 1 | 2016 | 169 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2016 | 454 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2017 | 790 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 1338 | 0.030 |
Why?
|
| Quality of Life | 1 | 2022 | 2162 | 0.020 |
Why?
|
| Adult Survivors of Child Abuse | 1 | 2012 | 16 | 0.020 |
Why?
|
| Exome | 1 | 2017 | 1087 | 0.020 |
Why?
|
| Proteins | 1 | 2017 | 1100 | 0.020 |
Why?
|
| Family Conflict | 1 | 2011 | 18 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 1835 | 0.020 |
Why?
|
| Personality | 1 | 2011 | 115 | 0.020 |
Why?
|
| Personality Disorders | 1 | 2011 | 163 | 0.020 |
Why?
|
| Age Factors | 1 | 2011 | 2997 | 0.010 |
Why?
|
| Adolescent | 2 | 2012 | 20643 | 0.010 |
Why?
|
| Young Adult | 1 | 2011 | 9960 | 0.010 |
Why?
|
| Child | 1 | 2012 | 25911 | 0.010 |
Why?
|